Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.

Details

Language :

English

ISSN :

01920790

Volume :

43

Issue :

7

Database :

Complementary Index

Journal :

Journal of Clinical Gastroenterology

Publication Type :

Academic Journal

Accession number :

105385121

Full Text :

https://doi.org/10.1097/MCG.0b013e318188947c